Clinical Trials Logo

Alcohol Dependence, in Remission clinical trials

View clinical trials related to Alcohol Dependence, in Remission.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03232112 Completed - Addiction, Alcohol Clinical Trials

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

EXALT
Start date: August 7, 2017
Phase: Phase 2
Study type: Interventional

The study is a double-blinded, randomized, placebo-controlled, 26-weeks clinical trial. The objective of the trial is to investigate the effects of the GLP-1 receptor agonist Bydureon® (exenatide) vs. placebo on alcohol intake in patients with a diagnosis of alcohol dependence.